DOMINICI, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 52.827
EU - Europa 23.490
AS - Asia 23.358
SA - Sud America 3.539
Continente sconosciuto - Info sul continente non disponibili 798
AF - Africa 596
OC - Oceania 119
Totale 104.727
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 51.254
IT - Italia 6.994
SG - Singapore 6.922
CN - Cina 5.759
GB - Regno Unito 4.981
SE - Svezia 3.436
HK - Hong Kong 2.742
VN - Vietnam 2.570
BR - Brasile 2.562
DE - Germania 2.056
BD - Bangladesh 1.344
FI - Finlandia 1.109
RU - Federazione Russa 937
CA - Canada 845
FR - Francia 804
KR - Corea 704
TR - Turchia 620
UA - Ucraina 617
IN - India 554
IE - Irlanda 544
ID - Indonesia 510
NL - Olanda 335
AR - Argentina 330
MX - Messico 313
JP - Giappone 311
BG - Bulgaria 292
ES - Italia 197
PL - Polonia 195
BE - Belgio 173
IQ - Iraq 172
ZA - Sudafrica 172
PK - Pakistan 146
CO - Colombia 136
EC - Ecuador 134
AT - Austria 127
AE - Emirati Arabi Uniti 124
AU - Australia 113
VE - Venezuela 108
CL - Cile 105
MY - Malesia 97
LT - Lituania 94
CZ - Repubblica Ceca 85
RO - Romania 81
MA - Marocco 75
PH - Filippine 72
CR - Costa Rica 70
UZ - Uzbekistan 70
KE - Kenya 68
TW - Taiwan 68
CH - Svizzera 64
IR - Iran 64
EG - Egitto 62
JM - Giamaica 60
SA - Arabia Saudita 59
JO - Giordania 54
PE - Perù 53
AL - Albania 49
PY - Paraguay 48
IL - Israele 46
DZ - Algeria 44
NO - Norvegia 44
TH - Thailandia 43
TN - Tunisia 43
HN - Honduras 38
NP - Nepal 37
PT - Portogallo 34
UY - Uruguay 31
SI - Slovenia 30
SV - El Salvador 29
TT - Trinidad e Tobago 29
GT - Guatemala 28
AZ - Azerbaigian 27
LB - Libano 27
KZ - Kazakistan 26
NI - Nicaragua 26
RS - Serbia 26
BO - Bolivia 24
DO - Repubblica Dominicana 24
DK - Danimarca 23
OM - Oman 23
PR - Porto Rico 23
BY - Bielorussia 22
EE - Estonia 22
HR - Croazia 19
SY - Repubblica araba siriana 19
ET - Etiopia 18
GR - Grecia 18
SN - Senegal 18
SK - Slovacchia (Repubblica Slovacca) 17
EU - Europa 16
NG - Nigeria 16
QA - Qatar 16
BB - Barbados 15
BZ - Belize 15
CY - Cipro 15
PA - Panama 15
GE - Georgia 14
HU - Ungheria 14
AM - Armenia 13
CI - Costa d'Avorio 13
Totale 103.680
Salva come PNG Salva come JPEG
Città #
Ashburn 7.002
Singapore 4.397
Santa Clara 4.062
Fairfield 3.777
San Jose 2.770
Southend 2.704
Hong Kong 2.658
Chandler 2.272
Council Bluffs 2.151
Woodbridge 1.984
Stockholm 1.835
Hefei 1.775
Houston 1.622
Seattle 1.405
Wilmington 1.205
Cambridge 1.178
Los Angeles 1.115
Ann Arbor 1.111
Beijing 1.075
London 1.052
Nyköping 974
Jacksonville 971
Chicago 939
New York 914
Ho Chi Minh City 864
Dearborn 846
Helsinki 835
Modena 738
Dallas 658
Seoul 656
Milan 622
Hanoi 617
The Dalles 597
Munich 524
Bologna 517
Dublin 502
San Diego 437
Jakarta 361
Salt Lake City 324
Buffalo 323
Lauterbourg 317
Izmir 307
Princeton 305
São Paulo 295
Moscow 293
Rome 292
Shanghai 287
Sofia 276
Frankfurt am Main 243
Tokyo 229
Phoenix 226
Toronto 204
Columbus 200
Eugene 197
Boardman 189
Orem 188
Tampa 164
Parma 158
Atlanta 157
Elk Grove Village 151
Montreal 145
Reggio Emilia 142
Warsaw 141
Naples 135
Redwood City 129
Denver 128
Berlin 127
Brooklyn 127
Des Moines 127
Brussels 123
Mexico City 123
Nuremberg 121
Falls Church 119
Bremen 114
Mcallen 109
Fremont 108
Guangzhou 108
Da Nang 106
Chennai 103
Montréal 103
Amsterdam 101
Johannesburg 101
Lancaster 98
Rio de Janeiro 98
Miami 93
Florence 92
Manchester 90
Haiphong 88
Kent 87
San Francisco 87
Redondo Beach 76
Sterling 73
Newark 70
Philadelphia 70
Charlotte 67
Boston 66
Verona 65
Detroit 64
Turku 64
Norwalk 63
Totale 69.098
Salva come PNG Salva come JPEG
Nome #
A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology. 2.243
0.1 grams of sub-cutaneous adipose tissue (SCAT) as source of adult multipotent mesenchymal stromal cells (MSC) for cell-based therapies 791
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement 675
Dynamic cultivation of mesenchymal stem cell aggregates 669
CD271 Mediates Stem Cells to Early Progeny Transition in Human Epidermis 525
Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy 498
Impressive response to dose-dense chemotherapy in a patient with NUT midline carcinoma 489
Rigenerand srl - Spin off Università di Modena e Reggio Emilia 473
Phase I study of intraperitoneal MHC unrestricted adoptive cell therapy with TALL-104 cells in patients with peritoneal carcinosis 454
Adipose stromal/stem cells assist fat transplantation reducing necrosis and increasing graft performance. 450
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer 447
GD2 expression in breast cancer. 446
Autologous Porcine Bone Marrow Mesenchymal Cells for Reconstruction of a Resorbed Alveolar Bone: A Preclinical Model in Mini-Pigs 444
Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: A joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT) 441
Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy 441
MSC-delivered soluble TRAIl and paclitaxel as novel combinatory treatment for pancreatic adenocarcinoma 438
GMP-manufactured density gradient media for optimized mesenchymal stromal/stem cell isolation and expansion. 436
The puzzling situation of hospital exemption for advanced therapy medicinal products in Europe and stakeholders' concerns 431
Lack of confirmation of an association between HTLV-I infection and myelodysplastic syndrome 423
Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies 423
Impact of time to surgery after neoadjuvant chemotherapy in operable breast cancer patients 421
Interstitial Lung Disease in Abemaciclib-treated Patients during SARS-CoV-2 Pandemic: A Case Series. 421
Microglia are less pro-inflammatory than myeloid infiltrates in the hippocampus of mice exposed to status epilepticus 420
A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing 415
Delayed marrow infusion in mice enhances hematopoietic and osteopoietic engraftment by facilitating transient expansion of the osteoblastic niche 412
MSC and Tumors: Homing, Differentiation and Secretion Influence The Therapeutic Potentials 412
Isolation, characterization, and transduction of endometrial decidual tissue multipotent mesenchymal stromal/stem cells from menstrual blood 407
Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis. 403
Suppression of invasion and metastasis of triple-negative breast cancer lines by pharmacological or genetic inhibition of slug activity 403
PCR con primer degenerati non evidenzia sequenze virali di HHV-8 ne di una sua variante in cellule stromali midollari di pazienti affetti da gammopatie monoclonali 402
SOLUBLE TRAIL-ARMED HUMAN AD-MSC AS NOVEL CELL THERAPY APPROACH FOR PANCREATIC DUCTAL ADENOCARCINOMA 401
Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors 401
cGMP-compliant transportation conditions for a prompt therapeutic use of marrow mesenchymal stromal/stem cells 398
Body composition and inflammation impact in non-small cell lung cancer patients treated by first-line immunotherapy 396
In vitro differentiation of human amniotic epithelial cells into insulin-producing 3D spheroids 395
Le Cellule Staminali Mesenchimali: Aspetti Biologici ed Approcci Terapeutici 393
Proteomics Analysis of Formalin-Fixed Paraffine-Embedded Tissue Reveals Key Proteins Related to Lung Dysfunction in Idiopathic Pulmonary Fibrosis. 390
Altered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistance 388
Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells 388
Clinical Prognosticators in Patients Treated with CDK 4/6 Inhibitors for Hormone Receptors Positive Advanced Breast Cancer 387
Clarification of the nomenclature for MSC: the international society for cellular therapy position statement 384
A novel function for amniotic fluid: original or authentic? 382
Transportation conditions for prompt use of Ex Vivo expanded and freshly harvested clinical-grade bone marrow mesenchymal stromal/stem cells for bone regeneration 378
Mesenchymal progenitors aging highlights a mir-196 switch targeting HOXB7 as master regulator of proliferation and osteogenesis 376
The phenotypes of microglia and macrophages during epileptogenesis 367
Potency biomarker signature genes from multiparametric osteogenesis assays: Will cGMP human bone marrow mesenchymal stromal cells make bone? 365
An alternative approach to investigate biofilm in medical devices: A feasibility study 364
Label-free toxicology screening of primary human mesenchymal cells and iPS-derived neurons 363
Correlating tumor-infiltrating lymphocytes and lung cancer stem cells: a cross-sectional study. 363
Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM 363
Circulating mucosal-associated invariant T cells identify patients responding to anti-PD-1 therapy 362
Osteopoietic engraftment after bone marrow transplantation: Effect of inbred strain of mice 357
Transplanted murine long-term repopulating hematopoietic cells can differentiate to osteoblasts in the marrow stem cell niche 356
Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas 356
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 356
Tumor Stroma Manipulation By MSC 355
Integrated intErventional bronchoscopy in the treatment of locally adVanced non-small lung cancER with central Malignant airway Obstructions: a multicentric REtrospective study (EVERMORE). 354
Feasibility and safety of treating non-unions in tibia, femur and humerus with autologous, expanded, bone marrow-derived mesenchymal stromal cells associated with biphasic calcium phosphate biomaterials in a multicentric, non-comparative trial 353
A new bioactive glass with extremely high crystallization temperature and outstanding biological performance 352
Nivolumab-Induced Impressive Response of Refractory Pulmonary Sarcomatoid Carcinoma with Brain Metastasis 351
International society for cellular therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials 351
Cancer stem-neuroendocrine cells in an atypical carcinoid case report. 350
An adoptive immuno-gene therapy approach targeting neuroblastoma. 349
Blocking tumor-educated MSC paracrine activity halts osteosarcoma progression 349
Comparison of single and dual platform methodologies for the estimation of CD34+ hematopoietic progenitor cells: correlation with colony assay 349
Human mesenchymal stem cell combined with a new strontium-enriched bioactive glass: An ex-vivo model for Bone Regeneration 349
Proteasome inhibitors sensitize colon carcinoma cells to TRAIL-induced apoptosis via enhanced release of Smac/DIABLO from the mitochondria 348
ALDH Expression in Angiosarcoma of the Lung: A Potential Marker of Aggressiveness? 347
Arming Mesenchymal Stromal/Stem Cells Against Cancer: Has the Time Come? 346
Overall survival in patients with lung adenocarcinoma harboring "niche" mutations: an observational study 345
Expression of HOXB7 in the lung of patients with idiopathic pulmonary fibrosis: a proof of concept study. 343
In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells. 343
Predictors of HER2 gene amplification in immunohistochemistry score 2+ Early Breast Cancer according to 2018 ASCO/CAP guidelines: a single institution analysis. 342
Thromboembolism (TE) and adjuvant endocrine therapy (AET) in hormone receptor positive (HR+) early breast cancer (EBC): Did the evolution of treatment change the incidence of the adverse event? A metanalysis 342
Molecular mechanisms and cellular contribution from lung fibrosis to lung cancer development. 338
Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single Institution analysis 337
METHOD FOR PRODUCTION OF ANTI-TUMOR TRAIL PROTEIN 335
Inhibiting interactions of lysine demethylase LSD1 with Snail/Slug blocks cancer cell invasion. 334
Detection of microparticles from human red blood cells by multiparametric flow cytometry 333
Clinical-Pathological Characteristics of HER2+ Breast Cancers patients among BRCA1/2+ carriers tested in Modena Cancer Center. 332
Assessing biocompatibility of face mask materials during covid-19 pandemic by a rapid multi-assays strategy 332
Modulation of Mutational Landscape in HER2-Positive Breast Cancer after Neoadjuvant Chemotherapy 331
Cytokine-Induced Osteopoietic Differentiation of Transplanted Marrow Cells 328
Rare breast cancer subtypes: Histological, molecular, and clinical peculiarities 327
Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation 327
Angiogenesis in multiple myeloma: Correlation between in vitro endothelial colony growth (CFU-En) and clinical biological features 327
Fibrotic idiopathic interstitial lung disease: the molecular and cellular key players. 326
Megakaryocytes promote murine osteoblastic HSC niche expansion and stem cell engraftment after radioablative conditioning 324
Cancer Stem-Like Cells in a Case of an Inflammatory Myofibroblastic Tumor of the Lung. 324
Mineralization by mesenchymal stromal cells is variously modulated depending on commercial platelet lysate preparations 323
Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers 321
Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma 321
Understanding Tumor-Stroma Interplays for Targeted Therapies by Armed Mesenchymal Stromal Progenitors: The Mesenkillers. 320
Bone marrow mesenchymal cells: biological properties and clinical applications. 318
Basic research and clinical applications of non-hematopoietic stem cells, 4-5 April 2008, Tubingen, Germany. 317
Predictive factors for relapse in triple-negative breast cancer patients without pathological complete response after neoadjuvant chemotherapy 315
Precision Medicine in Lung Cancer: Challenges and Opportunities in Diagnostic and Therapeutic Purposes. 315
Cell therapies for pancreatic beta-cell replenishment. 313
How do mesenchymal stromal cells exert their therapeutic benefit? 312
Progress in characterization, preparation and clinical applications of non-hematopoietic stem cells, 29-30 September 2006, Tübingen, Germany 310
Totale 40.240
Salva come PNG Salva come JPEG
Categoria #
all - tutte 403.607
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 403.607
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.955 0 0 0 346 281 473 400 409 648 522 1.072 804
2022/20237.282 818 781 539 662 740 904 188 654 1.158 135 404 299
2023/20245.108 257 309 365 493 817 499 512 599 154 196 287 620
2024/202516.755 493 224 488 1.141 2.682 2.476 1.410 980 1.958 1.128 1.615 2.160
2025/202638.311 2.329 1.396 3.035 4.275 5.747 2.164 4.219 1.798 5.050 3.546 2.698 2.054
2026/20279.875 1.145 2.061 2.827 3.842 0 0 0 0 0 0 0 0
Totale 104.727